The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Coming back to: Cost per delivered dose, which is the number that matters

This is a generated summary. It shows the 5 most-liked posts from a topic of 11, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
IL
integrator_logTL3Regular1 Dec 2024#1

On the subject in the title: Cost per delivered dose, which is the number that matters Working notes rather than a conclusion.

Documenting an access outcome, dated, because everything in this category expires.

As of January 2026, in my region, the position is as described below. I have linked the primary source rather than a summary of it, because the summaries are consistently a year behind.

If anyone can confirm or contradict this for their own region, please date your answer. An undated claim in this category is worse than no claim.

11 likes 20mo
TV
t.vasquezTL4 Moderator7 Dec 2024#2

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

15 likes 20mo
SD
s.dziedzicTL2 Moderator11 Dec 2024#3

post #2 is right about the mechanism and I think understates the practical bit.

Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.

30 likes 20mo
HD
h.delgadoTL2 Moderator19 Dec 2024#5

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

28 likes 19mo
CR
compounding_ruthTL4Pharmacist28 Dec 2024#8
so.cardoso, post #4: List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially. List price is not what anyone pays. Go to post

On post #4 — agreed on the reasoning, with one qualification.

International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US prices are higher than other developed nations.

9 likes in reply to #4 19mo

Read the full topic (11 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Revisiting: List price versus negotiated price versus what you pay
Revisiting: List price versus negotiated price versus what you pay — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
VKBVIABDGR+24 28 50k 12mo
Manufacturer assistance programmes and their eligibility rules
On the subject in the title: Manufacturer assistance programmes and their eligibility rules Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
TPHFRMIBCR+37 42 32k 11d
Pen wastage and its effect on real cost — the long version
Posting this under the heading it deserves: Pen wastage and its effect on real cost — the long version Everything below is what sits behind that. Documenting an access outcome, dated, because everything in…
EHAPSP 2 34k 13mo
About the Pricing category
List prices, negotiated prices, and cost per milligram compared honestly across formats. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
JMBNHFDTMP+1 5 18k 15mo
[2026 update] Comparing prices across jurisdictions without misleading yourself
On the subject in the title: Comparing prices across jurisdictions without misleading yourself Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
SDICP 2 809 23h

Related topics — sharing the tags formulary, data table, compounding

TopicParticipantsRepliesViewsActivity
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
YISVCDAMB+70 74 7k 8mo
What a regulator's shortage notice actually authorises
What a regulator's shortage notice actually authorises — that is the question, and I have not found it answered plainly anywhere I have looked. A logistics question, since the answers here are usually better…
BESCAAQLSG+8 12 15k 17h
Coming back to: Column chemistry choices for a 40-residue peptide
On the subject in the title: Column chemistry choices for a 40-residue peptide Working notes rather than a conclusion. Posting the method first, because I know what the first three replies will otherwise be.…
MLFPHB 2 43k 16mo
Seven-day rolling means and why weekly readings mislead
Seven-day rolling means and why weekly readings mislead Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss, which is the part of this that almost…
MDOZIMSAA+109 125 42k 10h
Irish differences from the UK position — what changed since
Irish differences from the UK position — what changed since — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in this category…
DOFNTIANPM+8 12 782 1d